iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionTwin Tree Management, LP
Latest Disclosed Ownership2,584 shares
Latest Disclosed Value $ 436,308
Twin Tree Management, LP ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Twin Tree Management, LP filed a 13F-HR form disclosing ownership of 2,584 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $436,308 USD as of March 31, 2026. The entity filed a previous 13F-HR on July 28, 2025 disclosing 0 shares of iShares Trust - iShares Biotechnology ETF. The current value of the position is $338,633 USD.

Twin Tree Management, LP has a history of taking positions in derivatives of the underlying security (0JGB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JGB / iShares Trust - iShares Biotechnology ETF Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TRUST ISHARES BIOTECH 464287556 2,584 2,584 436 0.0092
2025-07-28 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -20,002 -100.00 0 -100.00
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 20,002 20,002 2,558 0.0048
2023-05-10 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -6 -100.00 0 0.0000
2023-02-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6 -4,569 -99.87 1 -100.00 0.0000
2022-11-10 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,575 4,394 2,427.62 535 2,447.62 0.0010
2022-08-11 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 181 181 21 0.0000
2022-02-09 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -62,369 -100.00 0 -100.00
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 62,369 -257,142 -80.48 10,084 -80.71 0.0222
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 319,511 319,511 52,288 0.1403
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -671 -100.00 0 -100.00
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 671 671 102 0.0004
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -115,785 -100.00 0 -100.00
2020-08-12 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 115,785 115,785 15,827 0.0644
2018-11-09 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -8,051 -100.00 0 -100.00
2018-08-07 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 8,051 8,051 884 0.0054
2018-05-09 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -101,088 -100.00 0 -100.00
2018-02-09 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 101,088 88,404 696.97 10,793 155.09 0.0800
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 12,684 -7,657 -37.64 4,231 -32.92 0.0335
2017-08-10 2017-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 20,341 58 0.29 6,307 6.04 0.0493
2017-05-11 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 20,283 -12,343 -37.83 5,948 -31.30 0.0540
2017-02-13 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 32,626 32,626 8,658 0.0847
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F BLACKROCK INSTITUTIONAL TRUS ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-13 2025-09-30 13F BLACKROCK INSTITUTIONAL TRUS ISHARES BIOTECH Call 33,400 -89.38 4,822 -87.89 n/a n/a n/a
2025-07-28 2025-06-30 13F ISHARES TR ISHARES BIOTECH Call 314,600 39,800 n/a n/a n/a
2025-05-15 2025-03-31 13F BLACKROCK INSTITUTIONAL TRUS ISHARES BIOTECHNOLOG Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-10 2024-12-31 13F BLACKROCK INSTITUTIONAL TRUS ISHARES BIOTECHNOLOG Call 109,300 14,451 n/a n/a n/a
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH Call 28,700 0.00 3,939 0.03 n/a n/a n/a
2024-05-09 2024-03-31 13F ISHARES TR ISHARES BIOTECH Call 28,700 3,938 n/a n/a n/a
2022-02-09 2021-12-31 13F ISHARES TR ISHARES BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH Call 360,100 58,221 n/a n/a n/a
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH Call 45,600 6,175 n/a n/a n/a
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-09 2018-09-30 13F ISHARES TR NASDAQ BIOTECH Call 16,000 1,951 n/a n/a n/a
2018-05-09 2018-03-31 13F ISHARES TR NASDAQ BIOTECH Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F ISHARES TR NASDAQ BIOTECH Call 9,300 -83.71 993 -94.79 n/a n/a n/a
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH Call 57,100 0.00 19,048 7.58 n/a n/a n/a
2017-08-10 2017-06-30 13F ISHARES TR NASDAQ BIOTECH Call 57,100 332.58 17,706 357.40 n/a n/a n/a
2017-05-11 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF Call 13,200 1,366.67 3,871 1,519.67 n/a n/a n/a
2017-02-13 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF Call 900 239 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-09 2021-12-31 13F ISHARES TR ISHARES BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH Put 78,100 -73.74 12,627 -74.06 n/a n/a n/a
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH Put 297,400 48,670 n/a n/a n/a
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH Put 46,500 -75.68 6,297 -75.91 n/a n/a n/a
2020-08-12 2020-06-30 13F ISHARES TR NASDAQ BIOTECH Put 191,200 -56.58 26,135 -44.92 n/a n/a n/a
2020-05-13 2020-03-31 13F ISHARES TR NASDAQ BIOTECH Put 440,400 131.55 47,449 107.01 n/a n/a n/a
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH Put 190,200 -56.81 22,921 -51.69 n/a n/a n/a
2018-08-07 2018-06-30 13F ISHARES TR NASDAQ BIOTECH Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-09 2018-03-31 13F ISHARES TR NASDAQ BIOTECH Put 25,400 -94.41 2,711 -94.41 n/a n/a n/a
2018-02-09 2017-12-31 13F ISHARES TR NASDAQ BIOTECH Put 454,300 261.70 48,506 15.77 n/a n/a n/a
2017-11-13 2017-09-30 13F ISHARES TR NASDAQ BIOTECH Put 125,600 91.17 41,899 105.67 n/a n/a n/a
2017-08-10 2017-06-30 13F ISHARES TR NASDAQ BIOTECH Put 65,700 28.57 20,372 35.94 n/a n/a n/a
2017-05-11 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF Put 51,100 -61.87 14,986 -57.86 n/a n/a n/a
2017-02-13 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF Put 134,000 35,561 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.